Skip to NavigationSkip to content

Pharmafile - Research and Development News

FDA decision brings candidate a step closer to competing with Glivec and Sutent
Pfizer research Sandwich, Kent
Closure of company's Kent research base continues to cause waves in the UK
Paul Robinson, medical director at Merck Sharp & Dohme
How a desire to be more involved with clinical trials lead to a career with MSD
Roche Severin Schwann
Plans to file three key oncology drugs this year
But parallel study of lung cancer candidate necitumumab will continue
Sandwich R&D
Ministers failed to persuade Pfizer to retain UK R&D site
"Pfizer jobs could be tip of the iceberg" if research funding is cut too far
Pfizer's R&D site in Sandwich, Kent
Closure of historic Kent site is blow for UK
76% of target age group now protected
Phase III drug abandoned due to tolerability issues
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches